(%) 5.69% 9.51% 9.80% Return on Equity (%) 8.82% 15.44% 15.32% Efficiency Ratios Return on Assets (%) 6.27% 10.87% 10.68% Return on fixed assets (%) 46.78% 82.27% 89.99% Asset turnover times 1.10 1.14 1.09
performance that leads to value-added contribution to the shareholders. Size of the transaction calculated by criteria for total value of the return from = 269.96*100 consolidated financial statements as of
million. Due to total revenues decreased of Baht 554.20 million mainly from brokerage fees decreased of Baht 282.56 million, Gain and return on financial instruments decreased of Baht 326.45 million and
through Company Private Fund showing 21.55% higher return on investment, Baht 8.76 million upside from the business acquisition of scientific analytical and diagnostic for medical services, and gained of
from the return of stabilization function payment, which the company filed to Administrative Court. The Company recorded the revenue of THB 156 million while 1st quarter 2018, the Company does not have
baht and intense competition. Transaction For the Year ended 31st December Unit 2018 2017 Gross Profit Ratio % 14.58 15.60 Earnings Ratio % 3.15 4.88 Debt to Equity Ratio Time 0.27 0.29 Return on Equity
return on investment in private funds amount of THB 12.02 million, an increase of THB 11.72 million or 3,907 per cent. The profit from investment in associated company amount of THB 3.27 million, a
Ratio 12 Months 2019 12 Months 2018 Gross Profit Margin (%) 42.3 43.8 Net Profit Margin (%) 4.3 5.2 Return on Asset (%) 7.9 10.0 Return on Equity (%) 12.3 15.4 Current Ratio (Times) 1.7 1.6 Debt to Equity
). Revenue has increased 1.26 million baht (ratio 2.45%) due to sale local increased by 0.96 million baht, increasing return estimates 0.46 million baht, rental income increased 0.54 million baht, other
profit in 2Q17. Key Financial Ratio Financial ratio 2Q16 1Q17 2Q17 Current ratio 0.58 0.52 0.54 Debt to Equity ratio 1.53 2.00 1.91 Interest Bearing Debt to Equity ratio 0.40 0.58 0.67 Return on Asset 19.3